VTR:NYSE (USA) Also trade in: Germany UK

Ventas Inc

$ 59.03 0.74 (1.27%)
On watch
Volume: 1,565,854 Avg Vol (1m): 1,992,538
Market Cap $: 21.09 Bil Enterprise Value $: 31.81 Bil
P/E (TTM): 56.22 P/B: 2.06
Earnings Power Value -0.32
Net Current Asset Value -33.77
Tangible Book 21.47
Projected FCF 55.2
Median P/S Value 63.86
Graham Number 22.57
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 4/10

Current vs industry vs history
Cash-to-Debt 0.01
Equity-to-Asset 0.45
Debt-to-Equity 1.05
Debt-to-EBITDA 6.18
Interest Coverage 2.22
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.09
DISTRESS
GREY
SAFE
Beneish M-Score -2.68
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 5.09%
WACC 4.73%

Profitability & Growth : 7/10

Current vs industry vs history
Operating Margin % 26.24
Net Margin % 10.93
ROE % 3.87
ROA % 1.78
3-Year Total Revenue Growth Rate 4.50
3-Year Total EBITDA Growth Rate 0.90
3-Year EPS w/o NRI Growth Rate -0.30

» VTR's 30-Y Financials

Financials (Next Earnings Date: 2019-04-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:VTR

» Interactive Chart

Peter Lynch Chart

Business Description

Industry REITs » REIT - Healthcare Facilities    NAICS : 531190    SIC : 6798
Compare NYSE:WELL NYSE:HCP NYSE:OHI NYSE:HTA NYSE:MPW NAS:SNH NYSE:HR NAS:SBRA NYSE:NHI NYSE:GEO NYSE:DOC NYSE:QCP LSE:AGR NYSE:LTC SGX:C2PU NAS:CTRE TSX:NWH.UN NYSE:UHT SGX:AW9U NZSE:VHP
Traded in other countries VEN.Germany 0LO4.UK
Address 353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654
Recently, real estate investment trust Ventas owned interests in roughly 1,300 healthcare properties, including senior housing communities, skilled nursing facilities, medical office buildings, life science buildings, and hospitals. These properties are located throughout the United States and Canada. The firm also makes debt investments through mortgages and other loans.

Ratios

Current vs industry vs history
PE Ratio (TTM) 52.24
Forward PE Ratio 43.67
N/A
PE Ratio without NRI 56.22
Price-to-Owner-Earnings 19.06
PB Ratio 2.06
PS Ratio 5.66
Price-to-Free-Cash-Flow 16.97
Price-to-Operating-Cash-Flow 15.35
EV-to-EBIT 38.86
EV-to-EBITDA 18.30
EV-to-Revenue 8.49
Shiller PE Ratio 32.80
Current Ratio 0.28
Quick Ratio 0.28
Days Sales Outstanding 24.36
Days Payable 234.38

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 5.36
Dividend Payout Ratio 2.73
3-Year Dividend Growth Rate (Per Share) 1.30
Forward Dividend Yield % 5.37
N/A
Yield-on-Cost (5-Year) % 6.06
3-Year Share Buyback Rate -2.20

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 2.75
Price-to-Projected-FCF 1.07
Price-to-Median-PS-Value 0.93
Price-to-Peter-Lynch-Fair-Value 7.82
Price-to-Graham-Number 2.50
Earnings Yield (Joel Greenblatt) % 2.57
Forward Rate of Return (Yacktman) % 4.57

More Statistics

Revenue (TTM) (Mil) $ 3,745.81
EPS (TTM) $ 1.13
Beta 0.38
Volatility % 20.59
52-Week Range $ 46.55 - 65.7
Shares Outstanding (Mil) 357.35

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy Y